IL-23 came under the spotlight during this year’s European Academy of Dermatology and Venereology (EADV) Congress in Madrid, Spain, as the subject of a symposium co-chaired by Profs Reich and Warren, and with the latest data from the guselkumab clinical trial programme, reviewed in two separate articles in the latest addition to EMJ Dermatology.
14 Mins
5th
September
2023
